UY28994A1 - Acidos 4-trifluorometoxifenoxibenceno-`sulfnnicos, procedimiento para su preparacinn y su uso en medicamentos.- - Google Patents
Acidos 4-trifluorometoxifenoxibenceno-`sulfnnicos, procedimiento para su preparacinn y su uso en medicamentos.-Info
- Publication number
- UY28994A1 UY28994A1 UY28994A UY28994A UY28994A1 UY 28994 A1 UY28994 A1 UY 28994A1 UY 28994 A UY28994 A UY 28994A UY 28994 A UY28994 A UY 28994A UY 28994 A1 UY28994 A1 UY 28994A1
- Authority
- UY
- Uruguay
- Prior art keywords
- preparation
- sulfnnic
- acids
- procedure
- trifluorometoxifenoxibenceno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Rcidos 4-trifluorometoxifenoxibenceno-4`-sulfnnicos, procedimiento para su preparacinn y su uso en medicamentos. La invensinn se refiere a compuestos de la siguiente fnrmula (I) a los respectivos cloruro de sulfonilo, rcido sulfnnico, a derivados tales como sulfonamidas, y a un procedimiento para su preparacinn y a su uso como medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004031620A DE102004031620A1 (de) | 2004-06-30 | 2004-06-30 | 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln |
Publications (1)
Publication Number | Publication Date |
---|---|
UY28994A1 true UY28994A1 (es) | 2006-01-31 |
Family
ID=34970397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY28994A UY28994A1 (es) | 2004-06-30 | 2005-06-30 | Acidos 4-trifluorometoxifenoxibenceno-`sulfnnicos, procedimiento para su preparacinn y su uso en medicamentos.- |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070155778A1 (es) |
EP (1) | EP1763515B1 (es) |
JP (1) | JP4871273B2 (es) |
KR (1) | KR20070026662A (es) |
CN (1) | CN101035764A (es) |
AR (1) | AR049557A1 (es) |
AT (1) | ATE388940T1 (es) |
AU (1) | AU2005259634A1 (es) |
BR (1) | BRPI0512656A (es) |
CA (1) | CA2572126A1 (es) |
DE (2) | DE102004031620A1 (es) |
DK (1) | DK1763515T3 (es) |
ES (1) | ES2299039T3 (es) |
IL (1) | IL179975A0 (es) |
MX (1) | MXPA06014189A (es) |
MY (1) | MY139236A (es) |
PE (1) | PE20060478A1 (es) |
PT (1) | PT1763515E (es) |
TW (1) | TW200612943A (es) |
UY (1) | UY28994A1 (es) |
WO (1) | WO2006002764A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
DE102005002500A1 (de) | 2005-01-19 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen |
JP2010527731A (ja) | 2007-05-31 | 2010-08-19 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | システムアイロン用の固定装置 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0861236T4 (da) * | 1995-11-13 | 2006-12-18 | Sanofi Aventis Deutschland | Cykliske og heterocykliske N-substituerede alphaiminohydroxam- og carboxylsyrer |
IL128666A (en) * | 1996-08-28 | 2005-09-25 | Procter & Gamble | Substituted cyclic amine metalloprotease inhibitors |
AU7294098A (en) * | 1997-05-09 | 1998-11-27 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
US20010039287A1 (en) * | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
NZ503485A (en) * | 1997-11-14 | 2002-10-25 | G | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
DE102004031850A1 (de) * | 2004-06-30 | 2006-01-26 | Sanofi-Aventis Deutschland Gmbh | Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
-
2004
- 2004-06-30 DE DE102004031620A patent/DE102004031620A1/de not_active Withdrawn
-
2005
- 2005-06-15 MX MXPA06014189A patent/MXPA06014189A/es active IP Right Grant
- 2005-06-15 KR KR1020067027482A patent/KR20070026662A/ko not_active Application Discontinuation
- 2005-06-15 AU AU2005259634A patent/AU2005259634A1/en not_active Abandoned
- 2005-06-15 ES ES05750284T patent/ES2299039T3/es active Active
- 2005-06-15 CN CNA2005800218369A patent/CN101035764A/zh active Pending
- 2005-06-15 BR BRPI0512656-8A patent/BRPI0512656A/pt not_active IP Right Cessation
- 2005-06-15 DE DE502005003219T patent/DE502005003219D1/de active Active
- 2005-06-15 WO PCT/EP2005/006416 patent/WO2006002764A1/de active IP Right Grant
- 2005-06-15 EP EP05750284A patent/EP1763515B1/de not_active Not-in-force
- 2005-06-15 CA CA002572126A patent/CA2572126A1/en not_active Abandoned
- 2005-06-15 AT AT05750284T patent/ATE388940T1/de not_active IP Right Cessation
- 2005-06-15 JP JP2007518485A patent/JP4871273B2/ja not_active Expired - Fee Related
- 2005-06-15 PT PT05750284T patent/PT1763515E/pt unknown
- 2005-06-15 DK DK05750284T patent/DK1763515T3/da active
- 2005-06-23 PE PE2005000727A patent/PE20060478A1/es not_active Application Discontinuation
- 2005-06-28 TW TW094121522A patent/TW200612943A/zh unknown
- 2005-06-28 AR ARP050102660A patent/AR049557A1/es not_active Application Discontinuation
- 2005-06-29 MY MYPI20052975A patent/MY139236A/en unknown
- 2005-06-30 UY UY28994A patent/UY28994A1/es unknown
-
2006
- 2006-12-11 IL IL179975A patent/IL179975A0/en unknown
- 2006-12-15 US US11/611,199 patent/US20070155778A1/en not_active Abandoned
-
2009
- 2009-12-21 US US12/643,162 patent/US20100099663A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2299039T3 (es) | 2008-05-16 |
AU2005259634A1 (en) | 2006-01-12 |
US20070155778A1 (en) | 2007-07-05 |
PE20060478A1 (es) | 2006-06-22 |
MY139236A (en) | 2009-09-30 |
BRPI0512656A (pt) | 2008-04-01 |
TW200612943A (en) | 2006-05-01 |
PT1763515E (pt) | 2008-04-07 |
WO2006002764A1 (de) | 2006-01-12 |
ATE388940T1 (de) | 2008-03-15 |
IL179975A0 (en) | 2007-05-15 |
US20100099663A1 (en) | 2010-04-22 |
JP2008504316A (ja) | 2008-02-14 |
DE502005003219D1 (de) | 2008-04-24 |
EP1763515B1 (de) | 2008-03-12 |
JP4871273B2 (ja) | 2012-02-08 |
DE102004031620A1 (de) | 2006-02-02 |
AR049557A1 (es) | 2006-08-16 |
DK1763515T3 (da) | 2008-06-16 |
EP1763515A1 (de) | 2007-03-21 |
CN101035764A (zh) | 2007-09-12 |
MXPA06014189A (es) | 2007-03-12 |
CA2572126A1 (en) | 2006-01-12 |
KR20070026662A (ko) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30444A1 (es) | Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos. | |
ECSP077271A (es) | Derivados de pirimidina | |
UY30472A1 (es) | Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones. | |
ECSP077259A (es) | Derivados de pirimidina | |
UY28732A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico, procesos para su preparación y su uso como medicamentos. | |
UY27891A1 (es) | Nuevos derivados de glicosido de tiofeno, procedimientos para la preparación de los mismos, medicamentos que contienen estos compuestos, y el uso de los mismos. | |
UY28122A1 (es) | Nuevos derivados de fluoroglicósidos heterocíclicos, medicamentos que contienen estos compuestos, y el uso de los mismos. | |
UY28123A1 (es) | Nuevos derivados de fluoroglicósidos aromáticos, medicamentos que contienen estos compuestos y sus usos. | |
BRPI0408347B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
ECSP088975A (es) | Nuevos análagos de piridina | |
UY29002A1 (es) | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia | |
BR112015007231A2 (pt) | derivados de pirroltriazinona como inibidores de pi3k | |
CO6640270A2 (es) | Morfolinopirimidad y su uso en terapia | |
UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
UY29325A1 (es) | Nuevos derivados de 2 - amino-piridina | |
UY29896A1 (es) | Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
ECSP045105A (es) | Derivados de sulfonamidas, su preparacion y su aplicación como medicamentos | |
UY33485A (es) | Derivados de acido(2-ariloxiacetilamino)fenilpropionico, procedimientos para su preparacion y uso de los mismos como medicamentos. | |
UY30856A1 (es) | Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk | |
NO20060155L (no) | Indol-4-sulfonamid derivater, deres fremstilling og deres anvendelse 5-HT-6 som modulatorer | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
PA8574701A1 (es) | Derivados de isoindolona, proceso de preparacion y compuestos intermedios de este proceso, su uso como medicamentos, y composiciones farmaceuticas que los contienen | |
ECSP099481A (es) | Compuestos de piridina y su uso como antagonistas de p2y12 | |
UY28994A1 (es) | Acidos 4-trifluorometoxifenoxibenceno-`sulfnnicos, procedimiento para su preparacinn y su uso en medicamentos.- | |
ECSP088116A (es) | Procedimiento para la sintesis de haluros de sulfonilo y sulfonamidas a partir de sales de acido sulfonico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DESI | Application deemed to be withdrawn |
Effective date: 20120418 |